Codexis Newswire

Comprehensive Real-Time News Feed for Codexis.

Results 1 - 20 of 35 in Codexis

  1. Alcohol Enzymes Market - Global Industry Growth, Size, Share, Trends,...Read the original story w/Photo

    Friday Jan 23 | PRWeb

    ... high feedstock and energy costs. Associated British Foods plc, Advanced Enzymes Technologies Ltd, Amano Enzymes Inc, Codexis Inc, Dyadic International Inc., Lesaffre Group, Roquette Freres, and The Soufflet Group are other key players in the alcohol ...

    Comment?

  2. Global Alcohol Enzymes Market Share, Analysis, Trends To 2020 by Grand View Research, Inc.Read the original story

    Thursday Jan 22 | PR-inside.com

    ... high feedstock and energy costs. Associated British Foods plc, Advanced Enzymes Technologies Ltd, Amano Enzymes Inc, Codexis Inc, Dyadic International Inc, Lesaffre Group, Roquette Freres, and The Soufflet Group are other key players in the alcohol ...

    Comment?

  3. Codexis Lowered to "Neutral" at ZacksRead the original story

    Friday Jan 16 | AmericanBankingNews.com

    ... on the stock. Zacks 's price objective would suggest a potential upside of 1.64% from the company's current price. Codexis ( NASDAQ:CDXS ) traded down 2.95% during mid-day trading on Friday, hitting $2.96. 42,173 shares of the company's stock traded ...

    Comment?

  4. Global Specialty Enzymes Market Size and Forecast Up to 2020 by Grand View ResearchRead the original story

    Thursday Jan 8 | PR.com

    ... Some leading players operating in the global specialty enzymes market include Advanced Enzyme Technology Ltd., Codexis Inc., Amano Enzyme Inc., Nagase & Co. Ltd., BASF, Roche Holding AG and Sanofi S.A. Grand View Research provides strategic ...

    Comment?

  5. Altor BioScience Corporation Announces the Appointment of Kevin Taylor as Chief Business OfficerRead the original story

    Tuesday Jan 6 | Freshnews

    ... of Nuron Biotech and held business development leadership roles at Cangene Corporation, Adolor Corporation and Codexis. Earlier in his career he held senior positions at Elan Corporation, AstraZeneca and Zeneca, Inc. Mr. Taylor has extensive ...

    Comment?

  6. Now Available: Global Biobased Polymers Market 2015-2019Read the original story

    Thursday Jan 1 | PR-inside.com

    ... * Cathay Industrial Biotech * Celanese Acetate * Cellana * Chromatin * Clariant * Cobalt Technologies * Coca Cola * Codexis * Comet Biorefining * Cosan * Coskata * Dow Chemicals * DSM * DuPont Industrial Biosciences * Dyadic * Eastman Chemical * ...

    Comment?

  7. Global Oleochemicals Market to Reach US$15 Million by 2018: Transparency Market ResearchRead the original story w/Photo

    Tuesday Dec 30 | GlobeNewswire

    ... major players in the global oleochemicals market include Genomatica, Gevo, Myriant, Amyris, Solazyme, International, Codexis, Wilmar, Metabolix, Emery Oleochemicals, Goldschmidt, and Evonic among other oleochemicals companies. Transparency Market ...

    Comment?

  8. Global Specialty Enzymes Market Outlook, Company Share To 2020: Grand View Research, Inc.Read the original story

    Dec 8, 2014 | M2.com

    ... Some leading players operating in the global specialty enzymes market include Advanced Enzyme Technology Ltd., Codexis Inc., Amano Enzyme Inc., Nagase & Co. Ltd., BASF, Roche Holding AG and Sanofi S.A. Request TOC of "Specialty Enzymes Market ...

    Comment?

  9. New Report - Global Specialty Enzymes Market Size, Share To 2020: Grand View Research, Inc.Read the original story

    Dec 7, 2014 | PR-inside.com

    ... Some leading players operating in the global specialty enzymes market include Advanced Enzyme Technology Ltd., Codexis Inc., Amano Enzyme Inc., Nagase & Co. Ltd., BASF, Roche Holding AG and Sanofi S.A. Request TOC of "Specialty Enzymes Market ...

    Comment?

  10. Codexis, Inc. Uses Its Codeevolver Protein Engineering Platform...Read the original story

    Dec 4, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced that it has developed a novel enzyme therapeutic product candidate for the potential treatment of phenylketonuria via oral administration. PKU is an inherited metabolic disorder in which the enzyme that converts the essential amino acid phenylalanine into tyrosine is deficient.

    Comment?

  11. Specialty Enzymes Market - Global Industry Growth, Size, Share,...Read the original story w/Photo

    Dec 4, 2014 | PRWeb

    ... Some leading players operating in the global specialty enzymes market include Advanced Enzyme Technology Ltd., Codexis Inc., Amano Enzyme Inc., Nagase & Co. Ltd., BASF, Roche Holding AG and Sanofi S.A. Grand View Research, Inc. is a U.S. based ...

    Comment?

  12. Codexis, Inc.To Present At The Main Event VII Conference On December 4Read the original story

    Nov 24, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will provide a corporate update at the LD Micro Main Event VII Conference, being held December 2-4, 2014 at The Luxe Hotel in Los Angeles, California. Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production.

    Comment?

  13. Codexis, Inc. Reports Financial Results For The Third Quarter And...Read the original story

    Nov 5, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced financial results for the third quarter and nine months ended September 30, 2014. "I am pleased with the solid progress we are making towards our goals for 2014.

    Comment?

  14. Codexis' (CDXS) CEO John Nicols on Q3 2014 Results - Earnings Call TranscriptRead the original story w/Photo

    Nov 4, 2014 | Seeking Alpha

    Good day ladies and gentlemen and welcome to Third Quarter 2014 Codexis Earnings Conference Call. My name is Kim and I will be your operator for today.

    Comment?

  15. Codexis, Inc. Appoints Merck & Co. Global Executive, To Board Of DirectorsRead the original story

    Nov 4, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Pam Cheng to its board of directors. Ms. Cheng is a 17-year veteran of Merck & Co.

    Comment?

  16. Codexis (CDXS) Set to Announce Quarterly Earnings on TuesdayRead the original story

    Oct 31, 2014 | AmericanBankingNews.com

    Codexis is scheduled to issue its quarterly earnings data on Tuesday, November 4th. Parties interested in registering for the company's conference call can do so using this link .

    Comment?

  17. Codexis, Inc. To Report Third Quarter 2014 Financial Results On November 4Read the original story

    Oct 21, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced it will report third quarter financial results after the close of market on November 4, followed at 4:30 p.m. Eastern Time by a conference call and audio webcast at www.codexis.com . Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production.

    Comment?

  18. Codexis, Inc. Appoints Biotechnology Industry Veteran, To Board Of DirectorsRead the original story

    Sep 22, 2014 | BioSpace

    Codexis, Inc. , a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the appointment of Kathleen Sereda Glaub to its board of directors. Ms. Glaub's 30-year career in leadership positions with drug development and technology companies will bring strong company-building and business strategy experience to the Codexis board.

    Comment?

  19. Rising Prominence of Sustainable Production Practices Drives the...Read the original story

    Sep 19, 2014 | PRWeb

    ... Ltd., Amano Enzyme Inc., Asahi Kasei Pharma Corporation, BASF SE, BioResource International Inc., Chr. Hansen A/S, Codexis Inc., DuPont Nutrition and Health, Direvo Biotech AG, Enzymatic Deinking Technologies LLC, Hayashibara Company, Novozymes A/S, ...

    Comment?

  20. Codexis Director Acquires $133,200 in StockRead the original story

    Aug 18, 2014 | AmericanBankingNews.com

    Codexis Director Patrick Y. Yang acquired 60,000 shares of Codexis stock in a transaction that occurred on Tuesday, August 12th.

    Comment?